[Therapeutic advances in geriatry. A report on 47 cases (author's transl)].
A group of 47 elderly patients with various ailments and aged between 66 and 99 years were treated with tiapride: very good results were obtained in 7 cases of severe buccofacial dyskinesia, though the dosage had to go as high as 800 mg/day; results were excellent in 2 cases, good in 9, moderate in 5, and nil in 3 out of 19 patients with agitated states; overall results were good (1 failure) in 8 cases of alcoholism (4 acute and 4 chronic); 8 good results and 4 failures were noted in 12 patients with either cancer pain, or pain following zoster or due to arthrosis or migraine. The product was very well-tolerated by these elderly patients.
D000368:Aged; D000435:Alcoholic Intoxication / Q000188:drug therapy; D000437:Alcoholism / Q000188:drug therapy; D001549:Benzamides / Q000627:therapeutic use*; D005260:Female; D005853:Geriatrics; D006801:Humans; D006816:Huntington Disease / Q000188:drug therapy; D008297:Male; D009069:Movement Disorders / Q000188:drug therapy; D010146:Pain / Q000188:drug therapy; D011595:Psychomotor Agitation / Q000188:drug therapy; D013976:Tiapamil Hydrochloride / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D001549:Benzamides; D013976:Tiapamil Hydrochloride
Apport thérapeutique en milieu gériatrique. A propos de 47 cas.